(Total Views: 705)
Posted On: 10/27/2020 6:38:17 PM
Post# of 155747
For sure. That will be something to keep an eye out for.
If we are fortunate enough to know in the coming weeks, that an HIV approval is likely coming for HIV in UK, within 90 days, the fundamentals of this stock change quite a bit IMO.
1) A clock to revenue creates FOMO
2) An expectation of revenue will create a higher floor for CYDY
3) Realization of revenues will accelerate every other indication that we are pursuing.
4) An approval in UK, opens up other countries and each one gets progressively easier, including US.
5) An approval for HIV makes approvals for COVID more likely.
I really hope this avenue pans out.
If we are fortunate enough to know in the coming weeks, that an HIV approval is likely coming for HIV in UK, within 90 days, the fundamentals of this stock change quite a bit IMO.
1) A clock to revenue creates FOMO
2) An expectation of revenue will create a higher floor for CYDY
3) Realization of revenues will accelerate every other indication that we are pursuing.
4) An approval in UK, opens up other countries and each one gets progressively easier, including US.
5) An approval for HIV makes approvals for COVID more likely.
I really hope this avenue pans out.
(9)
(0)
